Prosecution Insights
Last updated: April 19, 2026

Glaxosmithkline Intellectual Property (No 3) Limited

2 pending office actions

Portfolio Summary

2
Total Pending OAs
1
Final Rejections
1
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
17932200 SELECTIVE P2X3 MODULATORS HEITMEIER, KENDALL NICOLE 1621 Final Rejection Sep 14, 2022
17396378 RNAI AGENTS FOR HEPATITIS B VIRUS INFECTION VYAS, KEYUR ANILKUMAR 1637 Non-Final OA Aug 06, 2021

Managing Glaxosmithkline Intellectual Property (No 3) Limited's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month